Get more replies from employers
Send a job-specific resume in minutes.
Essange Reagents seeks a Technical Key Account Manager – MAT to drive international commercial growth of the MAT portfolio. You will develop and strengthen strategic relationships with pharmaceutical and diagnostics customers and support MAT adoption across global markets.
This highly visible role combines technical sales, strategic account management and scientific consultancy to translate complex concepts into commercially viable solutions for customers and drive Essange’s growth.
A global technical-commercial role focused on driving MAT adoption, strategic customer growth and long-term partnerships in an evolving international market.
As Technical Key Account Manager – MAT, you are responsible for driving the international commercial growth of Essange’s MAT portfolio. You develop and strengthen strategic customer relationships within the pharmaceutical and diagnostics industry and support customers in the adoption of MAT solutions across global markets.
This is a highly visible, customer-facing role combining technical sales, strategic account management and scientific consultancy. You identify commercial opportunities, manage long-term partnerships and translate complex scientific concepts into commercially relevant solutions for customers.
Working closely with pharmaceutical manufacturers, distributors and internal teams across sales, marketing, R&D and manufacturing, you play a key role in expanding Essange’s global market position. As MAT adoption continues to accelerate worldwide due to evolving regulations around animal-free pyrogen testing, you will contribute directly to Essange’s international commercial growth strategy.
With this being a newly created role, you will have significant ownership and the opportunity to shape the position and make a visible impact on the organisation’s future growth.
Essange Reagents is an international provider of high-quality diagnostic reagents with a strong scientific foundation in immunohematology and immunodiagnostics. Originating from Sanquin (the Dutch Blood Bank), Essange has operated independently since October 2022 and is now accelerating its global commercial growth.
From its headquarters in Amsterdam, Essange develops, manufactures and commercialises innovative solutions for laboratory diagnostics worldwide, including the Monocyte Activation Test (MAT); a cell-based alternative to rabbit-based pyrogen testing. With distribution in over 35 countries and increasing regulatory momentum supporting MAT adoption, Essange plays an active role in the global transition towards animal-free pyrogen testing.
With around 100 employees and a dedicated Sales & Marketing team, Essange combines strong scientific expertise with an increasingly commercial, international mindset, offering a dynamic environment where innovation, customer impact and growth come together.